Cargando…
A clinical trial to evaluate the effect of statin use on lowering aldosterone levels
BACKGROUND: Statins are the first-line pharmaceutical agent in the management of hypercholesterolemia and cardiovascular (CV) risk reduction, and the most commonly prescribed class of drugs worldwide. Studies describing CV risk reduction independent of LDL-cholesterol lowering have evoked an interes...
Autores principales: | Hornik, Ezra S., Altman-Merino, Anne E., Koefoed, Andrew W., Meyer, Kayla M., Stone, Isabella B., Green, Jessica A., Williams, Gordon H., Adler, Gail K., Williams, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362429/ https://www.ncbi.nlm.nih.gov/pubmed/32664962 http://dx.doi.org/10.1186/s12902-020-00587-4 |
Ejemplares similares
-
SAT-356 Differential Effects of Lipophilic and Hydrophilic Statins on Aldosterone Biosynthesis
por: Maris, Stephen, et al.
Publicado: (2019) -
Interplay Between Statins, Cav1 (Caveolin-1), and Aldosterone
por: Haas, Andrea V., et al.
Publicado: (2020) -
Does the aldosterone: renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study
por: Parthasarathy, Hari K, et al.
Publicado: (2007) -
Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism
por: Pilz, Stefan, et al.
Publicado: (2009) -
Rationale and design of a randomized trial on the impact of aldosterone antagonism on cardiac structure and function in diabetic cardiomyopathy
por: Leung, Melissa, et al.
Publicado: (2013)